News

A paper published in the prestigious journal, Science Immunology, explores the idea that studying bats’ responses to SARS-CoV-2 may provide key insights into how and when to best use existing therapies for COVID-19, and to develop new treatments.…  Read more

Hudson Institute is happy to announce the success of our researcher, Dr Doug Blank, in the new NHMRC Investigator Grant round.…  Read more

Taking lessons learned studying coral reefs, a Melbourne researcher is taking a plunge into the microorganisms that inhabit our insides.…  Read more

Congratulations to Dr Vijesh Vaghjiani, Postdoctoral Scientist in the Developmental and Cancer Biology Research group who has been awarded one of two Sarcoma Research Grants by Australia and New Zealand Sarcoma Association (ANZSA).…  Read more

There’s new hope for tens of thousands of Australian women, with researchers making a crucial discovery in the battle to detect endometriosis.…  Read more

RNA therapeutics comprise a rapidly expanding category of drugs that have the potential to revolutionise treatments for many diseases, including those currently deemed undruggable.…  Read more

Hudson Institute researchers Dr Daniel Croagh and Professor Brendan Jenkins have  received a share of the Australian Pancreatic Cancer Foundation’s (PanKind) 2020 Collaborative Research Grant to help accelerate…  Read more

Six Early Career Researchers have been chosen for the 2021 Hudson Institute Emerging Leaders program.…  Read more

Hudson Institute scientists have found that a hormone that can cause high blood pressure has been found to behave differently in young men and women, possibly paving the way for more targeted diagnosis and treatment.…  Read more

condition that affects about one in 10 women of reproductive age and more than 730,000 in Australia, after making a world-first discovery of the role endometrial stem/progenitor cells in the disease.…  Read more